Long empty hallway with polished floors and tall windows at sunset
on October 23, 2026

Happy Hippo Kratom Review: The Extracts, the Certificates and the Class Action

Listen to this page

Read by an AI voice. The full article is read aloud, top to bottom, including all three boxes. The five tables and the two images are on the page.

This Happy Hippo kratom review starts with the extracts, because that is where King K works. Happy Hippo, LLC, of Meridian, Idaho, sells mostly plain-leaf powders and capsules, but its extract line runs from tablets and shots to gummies, taffy and softgels, with lot-labeled certificates published for each product we found listed. Then there is the class action behind the "What happened to Happy Hippo?" searches. It has reached a notice of settlement. The terms are not on the docket.

If you are here because something went wrong after using a kratom product, read this part first. If someone is difficult to wake, is not breathing normally, is having a seizure, or is unresponsive, call 911.

Poison Control is 1-800-222-1222, around the clock, for a reaction that worries you; call with the product in your hand. The crisis lifeline is 988, by call or text. The federal treatment locator is findtreatment.gov.

Two things stated plainly. Kratom is not a treatment for opioid use disorder, and it is not a treatment for opioid or kratom withdrawal. The medicines with an evidence base behind them are buprenorphine, methadone and naltrexone. And we are a seller, not a clinic, so every clinical question raised on this page belongs with a clinician or one of the numbers above rather than with us.

Who wrote this, and what we sell

Checked October 19, 2026. King K wrote this review. On kingkkratom.com we sell liquid kratom extracts and kratom energy shots, which compete with Happy Hippo's shots, so read this as a competitor's review. No store in our group (King K, GRH Kratom, GUD Tonics, Rebel X Brands and kemalwhyte.com) sells Happy Hippo or any Happy Hippo, LLC product. Happy Hippo did not commission or pay for this review and has not seen it. There are no affiliate links. We are not affiliated with or endorsed by Happy Hippo, and its product names are its trademarks.

Where ours fall short, plainly. Happy Hippo's extract certificates carry metal, microbial and solvent panels that the King K certificate we checked, for Platinum lot 12242, does not. Our lab results page still forwards to our homepage. Happy Hippo is on the AKA's GMP Qualified list; King K is not. And our no-ship list is weaker than Happy Hippo's footer, which names Louisiana and Vermont. Ours does not name them as states.

Corrections: use the contact page on kingkkratom.com. Next review: January 19, 2027, or sooner if the settlement status report or dispositional papers due by October 26, 2026, are filed.

How we reviewed it

Documents only, read on October 19, 2026. We did not buy, taste, dose or lab-test any Happy Hippo product. We read happyhippo.com's product data, pages, policies and Terms; ten certificates; label images for three products; three federal dockets and the live case's complaint and July 2025 order; two FDA pages; the AKA's GMP list; and Idaho's page for House Bill 864. No score or grade, by the same method as our K Shot kratom review.

Happy Hippo kratom review: the quick verdict

What the documents show. Nine extract listings, all but Prime Hippo stating mitragynine per unit. Ten lot-labeled certificates from three named laboratories. Six single-unit lots measured 91 to 107 percent of the listed figure, Prime Hippo read 2.15 percent against 2.0 listed, and the gummy lot came to about 144 percent, by our arithmetic. The concentrated minor alkaloid was not detected, below quantitation or a trace on every extract lot we read.

What is missing. Settlement terms. The maker's name. Listing directions that match the labels. One no-ship list instead of two.

Who would want more. Gummy buyers; anyone who wants listing and label to agree on a serving; anyone following the lawsuit; anyone in a state the lists leave out.

The extract line, product by product

Prices for the sizes named, as listed on happyhippo.com on October 19, 2026. The per-100 mg column is ours.

Product, as listed Mitragynine, as listed Price Per 100 mg (ours) Stock
K-Surge Kratom Extract Tablets, 30-count 100 mg per tablet $104.95 $3.50 In stock.
K-Surge, 4-count pack 100 mg per tablet $12.59 $3.15 Sold out.
Kratom Energy Shot (Caffeine) 50 or 150 mg per 2 oz bottle $8.99 or $11.99 $17.98 or $7.99 In stock, with some 150 mg sizes and flavors sold out.
Kratom Energy Shot (Caffeine-Free) 50 or 150 mg per bottle $8.99 or $11.99 $17.98 or $7.99 Sold out.
Kratom Extract Shot, 10 mL 60 or 120 mg per bottle $12.99 or $17.89 $21.65 or $14.91 In stock.
Kratom Gummies, bottle of 20 20 mg per gummy $28.98 $7.25 In stock.
Kratom Extract Taffy, bag of 30 20 or 50 mg per piece $54.99 or $89.99 $9.17 or $6.00 In stock, bar one flavor.
Kratom Extract Softgels, 30 30 mg per softgel $32.99 $3.67 Sold out.
Prime Hippo (Enhanced Kratom Powder) 2.0 percent; no mg on the label $13.99 (28 g) or $34.99 (112 g) $2.50 or $1.56 In stock.
K2 (Kava + Kratom Shot) 50 mg, with kava extract $9.79 $19.58 Sold out.

The arithmetic, once: price divided by listed milligrams, times 100, so the 30-tablet K-Surge bottle is $104.95 / 3,000 x 100 = $3.50 per 100 mg of mitragynine. It rests on label claims, not certificates; Prime Hippo's figure uses its listed 2.0 percent of the pack weight. By the same sum our own Rush shot comes to $10.00, Gold to $6.67 and Platinum to $5.60, so on listed milligrams K-Surge, the softgels and Prime Hippo all cost less than any King K product we could price.

Where the listing and the label disagree

We report what each document says. We do not reconcile them, and nothing here is an amount to take.

K-Surge. The listing gives "100 mg Mitragynine per tablet" and writes its directions in whole tablets. The label's Supplement Facts panel reads "Serving Size 1/2 Tablet", and its warning box counts in servings. Same tablet, two units.

The 150 mg energy shot. The listing sells "150mg Mitragynine (Kratom Extract) per 2 oz bottle". The label's panel divides the same bottle into three servings, and its warning box counts in servings, not bottles.

The taffy. The listing sets its 24-hour limit in milliliters, "5 mL", for a chew.

The certificates: measured against the listing

Happy Hippo's certificates page has a dropdown per product, 48 in all, with most entries labeled by lot. Three laboratories appear on the ten we read: Cora Science of Austin, Texas, also the laboratory on our own certificates; Anresco Laboratories of San Francisco; and ACS Laboratory of Sun City Center, Florida. Each states ISO/IEC 17025:2017 accreditation, which we took as printed.

Product, lot Listed Measured Laboratory, report Against listing
K-Surge Strawberry, H0326391 100 mg About 94.8 mg (ours) Anresco, Aug 2026 About 95 percent.
K-Surge Mint, H0326356 100 mg About 97.3 mg (ours) Anresco, Aug 2026 About 97 percent.
Prime Hippo, P2050726 2.0 percent 2.15 percent Cora Science, Jul 2026 Slightly over.
Softgels, HHKSG01 30 mg 27.3 mg Cora Science, Apr 2026 91 percent.
Gummies, 26021920MITB 20 mg About 28.7 mg (ours) ACS Laboratory, Mar 2026 About 144 percent.
Taffy, HHC20K1225 20 mg 21.1 mg Cora Science, Jan 2026 105.5 percent.
Extract Shot, 7115 60 mg 63.84 mg Anresco, Jun 2026 106.4 percent.
Energy Shot, caffeine-free, 6305 150 mg 160 mg Cora Science, Feb 2026 107 percent.

The K-Surge figures are ours: percent mitragynine times tablet weight, 15.057 percent of 0.6299 g and 15.465 percent of 0.6292 g. So is the gummy's. ACS reports 5.2270 mg per gram in a 5.5 g gummy, and 5.2270 x 5.5 is about 28.7 mg against the "20mg" in the listing and on the report's product line. One batch. The certificate prints no mitragynine figure per gummy, only total alkaloids per serving (31.735 mg), so read 144 percent as our calculation, not as a finding that the gummy is mislabeled.

All eight extract and enhanced-powder reports cover heavy metals, microbiology and residual solvents, and the gummy report adds pesticides and mycotoxins. Anresco's K-Surge and extract-shot reports list mitragynine pseudoindoxyl (MGPI) and MGM-15 as not detected; no report we read has an MGM-16 row. Anresco adds: "Results apply only to the sample(s) as received."

Gloved hands placing a small glass vial into a tray of vials in a lab instrument

On the concentrated minor alkaloid: not detected on both K-Surge lots and the extract shot, below quantitation on the energy shot and the gummy, and a trace on Prime Hippo, the softgel and the taffy. The K-Surge reports print no detection limit for that table, so "not detected" there means none found by that method, not zero. No listing is built on the minor alkaloid, MGPI, MGM-15 or MGM-16, though Happy Hippo's own labels do name the minor alkaloid.

That matters because on October 14, 2026, DEA published a notice of intent (91 FR 65370) proposing temporary Schedule I for the concentrated minor alkaloid and MGPI above 1 mg/g or 1 mg/mL, or with a mitragynine ratio below 100, with an order "on or after November 13, 2026", and said it is withdrawing its July notice. A proposal. No federal order on the minor alkaloid exists, while MGPI, MGM-15 and MGM-16 have been temporarily in Schedule I since August 26, 2026. We give no compliance verdict on any product, Happy Hippo's or ours, because a threshold applies to what is in a lot, not to a kind of product.

Here the comparison turns on us. K-Surge's direct competitor in our group is KING K PRIME, our extract tablet, purchasable on grhkratom.com at $34.99 for a blister of four on October 19, 2026. That page links the certificate for lot 080826. The certificate for another lot, 02122026, is still publicly reachable, and it printed the concentrated minor alkaloid at 1086 ppm against a limit of not more than 400 ppm and marked it FAIL; both current K-Surge lots read not detected. And King K Platinum, on sale at $28.00, links a certificate for lot 12242 reporting MGPI at 2.59 ug/g. On these documents, the tablet comparison does not favor King K.

Whoever you buy from, ask for the certificate for the lot in your hand. For a King K product, ask us through our contact page.

The leaf range, in brief

Most of the catalog is plain leaf: more than thirty named powders, plus capsules of 500 mg of powder each, at $8.99 to $11.99 for 1 oz and $199.99 to $224.99 a kilo before sales, as listed. None states its mitragynine content except where a "High MIT" batch percentage is printed, and Thailand White's "1.52% MIT" matches its certificate. Here "High MIT" means the leaf's mitragynine percentage, not the minor alkaloid. The two leaf reports we read put lead at 0.617 and 0.527 ug/g, against a specification of not more than 5.00 ug/g.

The Happy Hippo class action: which case is live

The classaction.org report that turns up in searches for the brand is a news item published on October 8, 2024, and last updated on January 30, 2026, and it does not report the later docket history. Its case number, 2:24-cv-08566, is in the Central District of California, and that case is over. Filed on October 4, 2024, it was voluntarily dismissed by the plaintiff on October 9, 2024, five days later.

The live case is No. 2:24-cv-02849 in the Eastern District of California, filed on October 10, 2024, by a California consumer proceeding under a pseudonym, for a proposed nationwide class and a California class. Its claims include three California consumer statutes, implied warranty and fraud by omission.

The core allegation reads: "Defendant intentionally failed to disclose these material facts regarding the dangers of kratom consumption anywhere on its Products' labeling, packaging, website, or marketing material." The complaint also alleges that the branding appeals to young consumers. Allegations, all of them. None has been proved.

On July 16, 2025, the court dismissed one claim, implied warranty, for lack of privity and with leave to amend, and denied the rest of Happy Hippo's motion. It was a pleading-stage ruling that took the allegations as true for that purpose, and it found nothing to be true. The order records Happy Hippo's argument that it "has already sufficiently disclosed the addictive nature of kratom on its website"; the court treated the claim as one about packaging.

Date On the Eastern District docket
August 13, 2025 Happy Hippo answers the complaint.
March 6, 2026 Case stayed pending mediation.
June 24, 2026 "NOTICE of SETTLEMENT by Happy Hippo, LLC."
September 24, 2026 A settlement status report or dispositional documents due by October 26, 2026.

So, as CourtListener's copy of the docket stood on October 19, 2026: a notice of settlement, no terms on the docket, nothing saying whether it is individual or class-wide, and no approval or dismissal. "Happy Hippo settled the class action" says more than the docket does. If you see the papers before we do, send them through our contact page. A second federal case, No. 1:25-cv-00582 in the Middle District of North Carolina, named Happy Hippo, LLC and was voluntarily dismissed on May 28, 2026; no documents from it are on CourtListener's RECAP archive, so we do not know its subject.

On October 19, 2026, every product page ended with a warning that "Kratom interacts with opioid receptors and may be habit-forming and lead to dependence." The images carrying it are dated August 13, 2025, in the product data; the complaint, in 2024, described only a collapsed dropdown. The documents do not say why it changed.

What FDA has published about Happy Hippo

FDA's heavy-metals analysis, current as of April 3, 2019, tested 30 kratom products and "found significant levels of lead and nickel at concentrations that exceed safe exposure for oral daily drug intake." Three rows name "Happy Hippo LLC" as the source.

Product, as FDA lists it Nickel (ng/g) Lead (ng/g)
Red Hot Hippo Maeng Da Red 1990 770
RockStar Hippo Maeng Da White 2680 1400
Sunshine Hippo Maeng Da Gold 1360 406

The units are nanograms per gram; 1400 ng/g is 1.4 ug/g. FDA's exposure comparison rests on heavy use. Its statement that "the typical long-term kratom user could potentially develop heavy metal poisoning" is about kratom generally, not one seller, and the page is laboratory data rather than a warning letter, recall or advisory. Happy Hippo's 2026 powder certificates read lead at 0.508 to 0.617 ug/g. Different lots, laboratories, methods and years, so no trend in either direction can be read from the two. The brand says it "has never been caught up in any recalls or contamination issues".

Blank stack of paper and a green leaf on a dark desk under a lamp

Searching fda.gov, we found no FDA warning letter, recall or safety alert naming the company, but we did not query the warning-letter or recall databases directly. Not found, not none.

The AKA GMP list, and the word "accredited"

Happy Hippo is on the American Kratom Association's GMP Qualified list as "Happy Hippo Herbals", in its own words a "small-family business in Boise ID that specializes in super high-quality plain-leaf Kratom". The list shows no audit dates. The AKA says vendors "must complete an annual independent 3rd party audit" and that a listing "should not be construed as the AKA's endorsement".

The brand goes further. A December 2025 post on its site describes "a packaging (manufacturing) laboratory accredited by the American Kratom Association", and the homepage claims "GMP-certified quality standards". GMP Qualified covers facilities and processes, not products, and the AKA's list does not use the word accredited. King K is not on the list.

Idaho House Bill 864, and Happy Hippo's campaign

Happy Hippo's site carries a campaign page against Idaho House Bill 864, which the legislature summarizes as amending law "to provide that certain substances involving mitragynine shall be Schedule I controlled substances." The bill was introduced on March 10, 2026, and referred to Health & Welfare, with no later action shown. Happy Hippo's page said "KRATOM IS ABOUT TO BE BANNED IF WE DON'T STOP HB864." and that lawmakers would vote on March 18. The legislature's page shows no vote, only introduction and referral, and notes that its statuses are unofficial until the final journal.

Company, terms, age, refunds and three no-ship lists

The site and labels name Happy Hippo, LLC, of Meridian, Idaho; the AKA says Boise; the complaint alleges Jurupa Valley, California. The labels we read say "PACKAGED EXCLUSIVELY FOR" or "Manufactured Exclusively For" Happy Hippo and do not name the maker.

The Terms, updated August 26, 2026, contain "A BINDING ARBITRATION PROVISION AND CLASS ACTION WAIVER": AAA consumer arbitration in Boise or another agreed place, an opt-out by certified mail, Idaho law, and a waiver of "any consumer protection laws outside the State of Idaho". The K-Surge label repeats the arbitration notice. What a court makes of that is for counsel. The Terms also cite FDA Import Alert 54-15, under which FDA districts may detain kratom dietary supplements and bulk ingredients from firms on its Red List without physical examination; Happy Hippo is not on its firm lists.

An age gate asks "Are you 21 years of age or older?"; we did not test the checkout. Refunds: "full refunds within 60 days of your confirmed delivery date" for unused products, a replacement for opened ones. A package lost or stolen after confirmed delivery is not Happy Hippo's responsibility unless the buyer paid for package protection.

No-ship list States Localities
Happy Hippo footer and shipping policy AL, AR, IN, LA, VT, WI Four, in FL, NC, CO and CA.
Happy Hippo Terms AL, AR, IN, LA, RI, VT, WI Eight, in FL, CA, IL and MS.
Happy Hippo homepage, October 2024, as quoted in the complaint AL, AR, IN, RI, VT, WI Four, in FL, NC, CO and CA.
King K shipping policy AL, AR, IN, RI, MA, WI Eleven, in FL, CA, IL, MS and LA.

None of Happy Hippo's three lists names Tennessee, North Dakota or Connecticut. Connecticut's Department of Consumer Protection says its kratom regulations "are now in effect"; a Tennessee agency summary says Public Chapter 950, effective July 1, 2026, "criminalizes knowingly possessing or distributing kratom"; and North Dakota's governor said on September 4, 2026, that kratom sales remain prohibited there until rules are in place. We did not test whether checkout blocks those states. Ours is weaker still: it omits the same three, and Louisiana and Vermont as states too.

What Happy Hippo claims

The effect claims are the brand's: menu collections named Discomfort Relief, Restful Sleep and Super Energy, and a "Kratom Saves Lives T-Shirt". We name them only as claims and did not test them. Kratom is not a treatment for anything. The homepage promises "Third-party lab testing on every batch"; the ten certificates we read fit that for the lots we checked, but ten files cannot prove every batch.

Happy Hippo kratom questions

What happened to Happy Hippo?

A California consumer sued Happy Hippo, LLC in October 2024, alleging that its packaging did not warn of kratom's addiction and dependence risks. Happy Hippo filed a notice of settlement on June 24, 2026. No terms are on the docket as of October 19, 2026, and nothing has been proved.

Is the case on classaction.org the live one?

No. It cites No. 2:24-cv-08566 in the Central District of California, dismissed by the plaintiff on October 9, 2024. The live case is No. 2:24-cv-02849 in the Eastern District.

Does Happy Hippo publish lab results for its extracts?

Yes, lot-labeled, from three named laboratories, with heavy-metal, microbiology and solvent panels on every extract report we read.

Has the FDA taken action against Happy Hippo?

Our searches found no FDA warning letter, recall or safety alert naming it. FDA's 2019 heavy-metals page lists three Happy Hippo powders; that is laboratory data, not enforcement.

Is Happy Hippo AKA GMP certified?

It is on the AKA's GMP Qualified list, which covers facilities and processes, not products, and is not an endorsement. King K is not on the list.

Disclaimer: this page summarizes public documents as read on October 19, 2026, and links to them so you can check. Lab results describe the samples tested, and statements in a complaint are allegations, not findings. It is general information, not legal or medical advice, and no substitute for counsel or for a clinician. Statements about botanical products have not been evaluated by the Food and Drug Administration, and no product is intended to diagnose, treat, cure or prevent any disease.


more Blog posts